Demonstrate Your Biomarker & Diagnostics Capabilities to Japan’s Pharmaceutical Leaders
As the Japanese pharmaceutical market continued to surge, this goldmine market was seeking innovative, intelligent diagnostics solutions to enable successful CDx co-development. From biomarker & IVD platforms to regulatory consultancy, digital pathology tools to clinical sample testing, your solutions were in demand amongst this audience of Japan’s decision-makers.
The Clinical Biomarkers & CDx Japan Summit was the only event dedicated to uniting international and local CDx leaders for unrivalled networking and learning. This was your opportunity to connect with global and domestic leaders, showcase your services, and keep your finger on the pulse of Japan’s unique CDx landscape.
Whether you were looking to establish yourself as a reliable and trusted diagnostic partner within this rapidly growing market or you wanted to strengthen your position to establish yourself as Japan’s go-to provider, this forum was where pivotal partnerships are formed, which powered the future of precision oncology.
What Did You Miss?
You Positioned Yourself as the Go-To Diagnostics Leader
You demonstrated your omics, diagnostics, and biomarker expertise through data-driven presentations, scientific posters, or panel discussions
You Connected with the Untapped Japanese Pharmaceutical Market
Partners built meaningful industry relationships with the thought leaders and decision makers driving precision medicine in Japan
Partners Uncovered Actionable Insights on Japan’s Unique CDx Strategy
You gained first-hand insight into evolving regulatory, reimbursement and commercialization priorities within Japan, direct from the experts
You Elevated Your Brand and Form Powerful Industry Partnerships
You shared your success stories, exemplified your customer service and forged industry-defining partnerships set to transform precision medicine both in Japan and internationally
2026 Key Interest Areas
Our pharmaceutical and academic audience was looking for technologies and solutions in the following areas:
- Biomarker platforms
- Companion diagnostic development
- Omics technologies
- Digital athology
- Imaging
- Sample testing
- Diagnostic labs
- Flow cytometry
- Regulatory support
Hear What Our Past Sponsors Have to Say
The ability to easily communicate with decision-makers and members in positions to influence decision-makers at various pharmaceutical companies, CDx providers, and CROs
Chief Executive Officer, Riken Genesis
I found the attendees to be very friendly and approachable and there was a great sense of community
Vice President of Clinical Testing, Almac
2026 Audience Composition
Company Type
Attendee Seniority
2026 Attending Companies Included
2026 Available Inventory
We had a range of inventory from standard booth and speaking slots to more bespoke deliverables such as lanyards, exclusive dinners and tours to help elevate your brand.
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.